📊 **PI Industries Q1 FY27: Profit Under Pressure Despite Strong Core Position**

🔬 **PI Industries** reported a weak set of Q1 FY27 numbers, with revenue and profitability declining sharply year-on-year. 📌 **Key Highlights:** • Consolidated Revenue: ₹1,702 Cr, down **10.4% YoY** • Consolidated PAT: ₹244 Cr, down **38.9% YoY** • EPS: ₹16.10 vs ₹26.37 YoY • Agrochemicals Revenue: ₹1,649 Cr, down **9.8% YoY** • Agrochemicals PBT: ₹384 Cr, down **32.2% YoY** • Pharma Revenue: ₹54 Cr, down **25% YoY** • Pharma remained loss-making with PBT loss of ₹82 Cr. 🔎 **Investor Takeaway** The core **Agrochemicals business continues to drive PI Industries**, but the sharp decline in segment profitability is the key concern. Pharma also remains under pressure. The absence of a fresh exceptional loss in Q1 provides some comfort, but the underlying earnings performance remains weak. Investors should closely track demand recovery, margins and the performance of the Pharma business in the coming quarters. 📉 **Verdict:** Q1 FY27 numbers are **weak**, with profitability declining much faster than revenue. 📢 Follow for more **results analysis, corporate actions & market insights.** ⚠️ **Disclaimer:** This post is for educational and informational purposes only and should not be considered investment advice. Please do your own research before making any investment decisions. $PIIND